IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank

Overview

Journal Kidney Int Rep

Publisher Elsevier

Specialty Nephrology

Date 2020 Oct 26

PMID 33102956

Citations 15

Authors

Kittiya Sukcharoen

Seth A Sharp

Nicholas J Thomas

Robert A Kimmitt

Jamie Harrison

Coralie Bingham

Monika Mozere

Michael N Weedon

Jessica Tyrrell

Jonathan Barratt

Daniel P Gale

Richard A Oram

Affiliations

Soon will be listed here.

Abstract

Background: IgA nephropathy (IgAN) is the commonest glomerulonephritis worldwide. Its prevalence is difficult to estimate, as people with mild disease do not commonly receive a biopsy diagnosis. We aimed to generate an IgA nephropathy genetic risk score (IgAN-GRS) and estimate the proportion of people with hematuria who had IgAN in the UK Biobank (UKBB).

Methods: We calculated an IgAN-GRS using 14 single-nucleotide polymorphisms (SNPs) drawn from the largest European Genome-Wide Association Study (GWAS) and validated the IgAN-GRS in 464 biopsy-proven IgAN European cases from the UK Glomerulonephritis DNA Bank (UKGDB) and in 379,767 Europeans in the UKBB. We used the mean of IgAN-GRS to calculate the proportion of potential IgAN in 14,181 with hematuria and other nonspecific renal phenotypes from 379,767 Europeans in the UKBB.

Results: The IgAN-GRS was higher in the IgAN cohort (4.30; 95% confidence interval [95% CI: 4.23-4.38) than in controls (3.98; 3.97-3.98; < 0.0001). The mean GRS in UKBB participants with hematuria ( = 12,858) was higher (4.04; 4.02-4.06) than UKBB controls (3.98; 3.97-3.98; < 0.0001) and higher in those with hematuria, hypertension, and microalbuminuria ( = 1323) (4.07; 4.02-4.13) versus (3.98; 3.97-3.98; = 0.0003). Using the difference in these means, we estimated that IgAN accounted for 19% of noncancer hematuria and 28% with hematuria, hypertension, and microalbuminuria in UKBB.

Conclusions: We used an IgAN-GRS to estimate the prevalence of IgAN contributing to common phenotypes that are not always biopsied. The noninvasive use of polygenic risk in this setting may have further utility to identify likely etiology of nonspecific renal phenotypes in large population cohorts.

Citing Articles

The association between type 1 diabetes mellitus and the risk of immunoglobulin A nephropathy: a Mendelian randomization study.

Zhang C, Shen Y, Zhao S Front Med (Lausanne). 2025; 11:1429369.

PMID: 39744534 PMC: 11690302. DOI: 10.3389/fmed.2024.1429369.

Association between constipation and incident chronic kidney disease in the UK Biobank study.

Kim K, Cho W, Hwang S, Lee S, Song J Sci Rep. 2024; 14(1):32106.

PMID: 39738665 PMC: 11686077. DOI: 10.1038/s41598-024-83855-w.

The pathogenesis of IgA nephropathy and implications for treatment.

Cheung C, Alexander S, Reich H, Selvaskandan H, Zhang H, Barratt J Nat Rev Nephrol. 2024; 21(1):9-23.

PMID: 39232245 PMC: 7616674. DOI: 10.1038/s41581-024-00885-3.

IgA Nephropathy: Emerging Mechanisms of Disease.

Roberts L, Williams C, Oni L, Barratt J, Selvaskandan H Indian J Nephrol. 2024; 34(4):297-309.

PMID: 39156850 PMC: 11326799. DOI: 10.25259/ijn_425_23.

Genetics of IgA nephrology: risks, mechanisms, and therapeutic targets.

Qu S, Zhou X, Zhang H Pediatr Nephrol. 2024; 39(11):3157-3165.

PMID: 38600219 DOI: 10.1007/s00467-024-06369-7.

References

Varis J, Rantala I, Pasternack A, Oksa H, Jantti M, Paunu E . Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death. J Clin Pathol. 1993; 46(7):607-10. PMC: 501386. DOI: 10.1136/jcp.46.7.607. View

McGrogan A, Franssen C, de Vries C . The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant. 2010; 26(2):414-30. DOI: 10.1093/ndt/gfq665. View

Das S, Forer L, Schonherr S, Sidore C, Locke A, Kwong A . Next-generation genotype imputation service and methods. Nat Genet. 2016; 48(10):1284-1287. PMC: 5157836. DOI: 10.1038/ng.3656. View

Inouye M, Abraham G, Nelson C, Wood A, Sweeting M, Dudbridge F . Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention. J Am Coll Cardiol. 2018; 72(16):1883-1893. PMC: 6176870. DOI: 10.1016/j.jacc.2018.07.079. View

Evangelou E, Warren H, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H . Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. 2018; 50(10):1412-1425. PMC: 6284793. DOI: 10.1038/s41588-018-0205-x. View

Khera A, Chaffin M, Aragam K, Haas M, Roselli C, Choi S . Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018; 50(9):1219-1224. PMC: 6128408. DOI: 10.1038/s41588-018-0183-z. View

Ai Z, Li M, Liu W, Foo J, Mansouri O, Yin P . Low α-defensin gene copy number increases the risk for IgA nephropathy and renal dysfunction. Sci Transl Med. 2016; 8(345):345ra88. DOI: 10.1126/scitranslmed.aaf2106. View

Thomas N, Jones S, Weedon M, Shields B, Oram R, Hattersley A . Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 2017; 6(2):122-129. PMC: 5805861. DOI: 10.1016/S2213-8587(17)30362-5. View

Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M . Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014; 46(11):1187-96. PMC: 4213311. DOI: 10.1038/ng.3118. View

10.

Imai E, Yamagata K, Iseki K, Iso H, Horio M, Mkino H . Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007; 2(6):1360-6. DOI: 10.2215/CJN.00980207. View

11.

Sharp S, Rich S, Wood A, Jones S, Beaumont R, Harrison J . Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis. Diabetes Care. 2019; 42(2):200-207. PMC: 6341291. DOI: 10.2337/dc18-1785. View

12.

Dudbridge F . Power and predictive accuracy of polygenic risk scores. PLoS Genet. 2013; 9(3):e1003348. PMC: 3605113. DOI: 10.1371/journal.pgen.1003348. View

13.

Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y . Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int. 2003; 63(6):2286-94. DOI: 10.1046/j.1523-1755.63.6s.2.x. View

14.

Barratt J, Feehally J . IgA nephropathy. J Am Soc Nephrol. 2005; 16(7):2088-97. DOI: 10.1681/ASN.2005020134. View

15.

Schena F, Nistor I . Epidemiology of IgA Nephropathy: A Global Perspective. Semin Nephrol. 2018; 38(5):435-442. DOI: 10.1016/j.semnephrol.2018.05.013. View

16.

Davey Smith G, Davies N . Can genetic evidence help us understand why height and weight relate to social position?. BMJ. 2016; 352:i1224. DOI: 10.1136/bmj.i1224. View

17.

Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F . Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012; 8(6):e1002765. PMC: 3380840. DOI: 10.1371/journal.pgen.1002765. View

18.

Gale D, Molyneux K, Wimbury D, Higgins P, Levine A, Caplin B . Galactosylation of IgA1 Is Associated with Common Variation in . J Am Soc Nephrol. 2017; 28(7):2158-2166. PMC: 5491291. DOI: 10.1681/ASN.2016091043. View

19.

Osman W, Okada Y, Kamatani Y, Kubo M, Matsuda K, Nakamura Y . Association of common variants in TNFRSF13B, TNFSF13, and ANXA3 with serum levels of non-albumin protein and immunoglobulin isotypes in Japanese. PLoS One. 2012; 7(4):e32683. PMC: 3338726. DOI: 10.1371/journal.pone.0032683. View

20.

Stower H . Bringing polygenic risk scores to the clinic. Nat Med. 2018; 24(9):1303. DOI: 10.1038/s41591-018-0190-8. View